Eun Joo Jung

Dr. Eun Joo Jung

Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Republic of Korea

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2004 in Oncogene
Verified
Journal Article
Closed access
AWAmy Willis
Amy Willis
Eun Joo JungEun Joo Jung
Eun Joo Jung
TWTherese Wakefield
Therese Wakefield
XCXinbin Chen
Xinbin Chen

1 March 2006 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
Eun Joo JungEun Joo Jung
Eun Joo Jung
GLGang Liu
Gang Liu
WZWenjing Zhou
Wenjing Zhou
XCXinbin Chen
Xinbin Chen
Myosin VI is an unconventional motor protein, and its mutation is responsible for the familiar conditions sensorineural deafness and hypertrophic cardiomyopathy. Myosin VI is found to play a key role in the protein trafficking and homeostasis of the Golgi complex. However, very little is known about how myosin VI is regulated and whether myosin VI has a function in the DNA damage response. Here, we found that myosin VI is regulated by DNA damage in a p53-dependent manner and possesses a novel function in the p53-dependent prosurvival pathway. Specifically, we show that myosin VI is induced by p53 and DNA damage in a p53-dependent manner. We found that p53 directly binds to, and activates, the promoter of the myosin VI gene. We also show that the intracellular localization of myosin VI is substantially altered by p53 and DNA damage in a p53-dependent manner such that the pool of myosin VI in endocytic vesicles, membrane ruffles, and cytosol migrates to the Golgi complex, perinuclear membrane, and nucleus. Furthermore, we show that knockdown of myosin VI attenuates activation of p53 and impairs Golgi complex integrity, which makes myosin VI-deficient cells susceptible to apoptosis upon DNA damage. Taken together, we found a novel function for p53 in the maintenance of Golgi complex integrity and for myosin VI in the p53-dependent prosurvival pathway.

1 March 2010 in Neuroscience Letters
Verified
Journal Article
Closed access
SDShorafidinkhuja Dadakhujaev
Shorafidinkhuja Dadakhujaev
HNHae Sook Noh
Hae Sook Noh
Eun Joo JungEun Joo Jung
Eun Joo Jung
JCJoon Yung Cha
Joon Yung Cha
SBSeon Mi Baek
Seon Mi Baek
DKDeok Ryong Kim
Deok Ryong Kim

Verified
Journal Article
Open access
PDF file
APAnjugam Paramanantham
Anjugam Paramanantham
Eun Joo JungEun Joo Jung
Eun Joo Jung
HKHye Jung Kim
Hye Jung Kim
BJBae Kwon Jeong
Bae Kwon Jeong
JJJin-Myung Jung
Jin-Myung Jung
WLWon Sup Lee
Won Sup Lee
Emerging evidence suggests that breast cancer stem cells (BCSCs), and epithelial–mesenchymal transition (EMT) may be involved in resistance to doxorubicin. However, it is unlear whether the doxorubicin-induced EMT and expansion of BCSCs is related to cancer dormancy, or outgrowing cancer cells with maintaining resistance to doxorubicin, or whether the phenotypes can be transferred to other doxorubicin-sensitive cells. Here, we characterized the phenotype of doxorubicin-resistant TNBC cells while monitoring the EMT process and expansion of CSCs during the establishment of doxorubicin-resistant MDA-MB-231 human breast cancer cells (DRM cells). In addition, we assessed the potential signaling associated with the EMT process and expansion of CSCs in doxorubicin-resistance of DRM cells. DRM cells exhibited morphological changes from spindle-shaped MDA-MB-231 cells into round-shaped giant cells. They exhibited highly proliferative, EMT, adhesive, and invasive phenotypes. Molecularly, they showed up-regulation of Cyclin D1, mesenchymal markers (β-catenin, and N-cadherin), MMP-2, MMP-9, ICAM-1 and down-regulation of E-cadherin. As the molecular mechanisms responsible for the resistance to doxorubicin, up-regulation of EGFR and its downstream signaling, were suggested. AKT and ERK1/2 expression were also increased in DRM cells with the advancement of resistance to doxorubicin. Furthermore, doxorubicin resistance of DRM cells can be transferred by autocrine signaling. In conclusion, DRM cells harbored EMT features with CSC properties possessing increased proliferation, invasion, migration, and adhesion ability. The doxorubicin resistance, and doxorubicin-induced EMT and CSC properties of DRM cells, can be transferred to parental cells through autocrine signaling. Lastly, this feature of DRM cells might be associated with the up-regulation of EGFR.

15 May 2001 in Journal of Virology
Verified
Journal Article
Closed access
ARAntonio Rodriguez
Antonio Rodriguez
Eun Joo JungEun Joo Jung
Eun Joo Jung
EFErik K. Flemington
Erik K. Flemington
While Epstein-Barr virus (EBV) latency-associated gene expression is associated with cell cycle progression, the relationship between the EBV lytic program and the cell cycle is less clear. Using four different EBV lytic induction systems, we address the relationship between lytic cycle activation and the cell cycle. In three of these systems, G 0 or G 1 cell growth arrest signaling is observed prior to detection of the EBV immediate-early gene product Zta. In tetradecanoyl phorbol acetate-treated P3HR1 cultures and in 5-iodo-2′-deoxyuridine-treated NPC-KT cultures, cell cycle analysis of Zta-expressing cell populations showed a significant G 1 bias during the early stages of lytic cycle progression. In contrast, treatment of the cell line Akata with anti-immunoglobulin (Ig) results in rapid induction of immediate-early gene expression, and accordingly, activation of the immediate-early gene product Zta precedes significant anti-Ig-induced cell cycle effects. Nevertheless, cell cycle analysis of the Zta-expressing population following anti-Ig treatment shows a bias for cells in G 1 , indicating that anti-Ig-mediated induction of Zta occurs more efficiently in cells traversing G 1 . Last, although 5-azacytidine treatment of Rael cells results in a G 1 arrest in the total cell population which precedes the induction of Zta, cell cycle analysis of the Zta-expressing population shows a significant bias for cells with an apparent G 2 /M DNA content. This bias may result, in part, from activation of Zta expression following demethylation of the Zta promoter during S-phase. Together, these studies indicate that induction of Zta occurs through several distinct mechanisms, some of which may involve checkpoint signaling.

1 June 2001 in Virology
Verified
Journal Article
Open access
PDF file
ARAntonio Rodriguez
Antonio Rodriguez
Eun Joo JungEun Joo Jung
Eun Joo Jung
QYQinyan Yin
Qinyan Yin
CCCorinne Cayrol
Corinne Cayrol
EFErik K. Flemington
Erik K. Flemington
Latency-associated Epstein–Barr virus (EBV) gene expression induces cell proliferation. Unlike the latency associated genes, lytic gene expression in EBV, as well as other herpesviruses, elicits cell cycle arrest. Previous studies have shown that the EBV immediate early lytic transactivator, Zta, induces a G0/G1 cell cycle arrest through induction of the cyclin-dependent kinase inhibitors, p21 and p27. Here we show that while EBV latency is intimately linked to activation of the protooncogene, c-myc, Zta represses c-myc expression. We also show that inhibition of c-myc expression is required for Zta-mediated growth arrest and for maximal induction of p21 and p27. Nevertheless, induction of p21 and p27 is also influenced by a c-myc-independent mechanism. A detailed genetic analysis of Zta's basic/DNA binding region identified two distinct subregions that contribute to full induction of p21 and p27. One subdomain influences p21 and p27 expression through the c-myc-dependent mechanism and the other subdomain influences p21 and p27 induction through the c-myc-independent pathway. Together, these studies further our understanding of the complex nature of Zta-induced growth arrest.